Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer
Kaichun Wu(Xijing Hospital), Zhenyuan Bian(Xijing Hospital), Bing Xu(Shandong Provincial QianFoShan Hospital), Shie‐Ming Peng(National Taiwan University), Na Chai(Xijing Hospital), Chao Jian(Wuhan University), Zuhong Tian(National Clinical Research Center for Digestive Diseases), Niu Huang(National Institute of Biological Sciences, Beijing), Xiaowei Li(Peking University), Di Chen(Shanghai Institute of Hematology), Jinpeng Wang(Xijing Hospital), Ying Zhang(Boston University), Jian Liu(Xijing Hospital), Guodong Wang(Kunming Institute of Zoology), Hao Hu(Unknown), Yongzhan Nie(Xijing Hospital), Hao Guo(Simcere Pharmaceutical (China)), Miaomiao Tian(China Academy of Transportation Sciences), Xiaofang Yi(Nanjing Agricultural University), Sijung Hu(Xijing Hospital), Pengfei Yu(Suzhou Traditional Chinese Medicine Hospital)
Cited by 41
Related Papers
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
|bioRxiv (Cold Spring Harbor Laboratory)|2021|480
Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis
|American Journal of Psychiatry|2016|348